WALTHAM, Mass.--(BUSINESS WIRE)--
PerkinElmer,
Inc. (NYSE: PKI), a global leader focused on improving the health
and safety of people and the environment, today announced that Peter
Barrett, a partner at Atlas Venture, an early stage technologies and
life sciences venture capital fund, has been elected to the Company's
Board of Directors, in anticipation of a current Board member reaching
retirement age.
"We are very excited to have Peter joining our Board," said Robert F.
Friel, chairman and chief executive officer of PerkinElmer, Inc. "Peter
brings decades of deep industry experience and knowledge of life
sciences and analytical instrumentation, gained in his international
leadership positions, as well as from his expertise as a leading
investor in scientific enterprises."
Prior to joining Atlas Venture in 2002 where he is focused on developing
new life science technologies, Barrett was a co-founder, executive vice
president and chief business officer of Celera Genomics. Previously,
Barrett held senior management positions at the former Perkin-Elmer
Corporation throughout the 1980s and 1990s, where he expanded the
Company's business presence in key segments and geographies.
Peter received his Bachelor of Science in Chemistry from Lowell
Technological Institute (now known as the University of Massachusetts,
Lowell) and his PhD in Analytical Chemistry from Northeastern University.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
approximately $1.7 billion in 2010, has about 7,000 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
PerkinElmer, Inc.
Mario Fante, 781-663-5602
Corporate Public
Relations Manager
mario.fante@perkinelmer.com
Source: PerkinElmer, Inc.
News Provided by Acquire Media